DAFTAR PUSTAKA. 1. Konsensus nasional : Pengenalan dan penatalaksanaan demensia alzheimer

62

DAFTAR PUSTAKA

1. Konsensus nasional : Pengenalan dan penatalaksanaan demensia alzheimer dan demensia lainnya. Edisi 1. Jakarta : Asosiasi Alzheimer Indonesia ; 2003. 2. Cerebrovascular disease. In : Victor M, Ropper AH, editors. Principles of Neurology. 8th ed. New York : McGraw-Hill ; 2005. p. 660-746. 3. Kurtzke JF. Epidemiology : Stroke, Pathophysiology, Diagnosis and Management. 1st ed. New York : Churchill Livingstone ; 1996. p. 3-19. 4. Gubitz G. Acute stroke management and prevention of recurrences. In : Candelise L, Hughes R. Liberati A, Uitdehaag BMJ, Warlow C, editors. Evidence-based neurology : management of neurological disorders. Minnesota : Blackwell Publishing ; 2007. p. 113 - 26. 5. Gusev, Skvorsova VI. Brain Ischemia. 1st ed. New York : Kluwer Academic/Plenum Publisher, 2003 : 1-72. 6. Sjahrir H. Stroke iskemik. Medan (Indonesia) : Yandira Agung Medan ; 2003. p. 1 -35. 7. Adams HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke : A guideline from the American Heart Association / American Stroke Association. Stroke. 2007 ; 38 : 1655 - 711 8. Lindsberg PJ, Roine RO. Hyperglycemia in acute stroke. Stroke. 2004 ; 35 : 363 - 64

63

9. Garg R, Chaudhuri A, Munschauer F, Dandona P. Hyperglycemia, insulin, and acute ischemic stroke : a mechanistic justification for a trial of insulin infusion therapy. Stroke. 2006 ; 37 : 267 - 73. 10. Vancheri F, Curcio M, Burgio A, Salvaggio S, Gruttadauria G, Lunetta MC, et al. Impaired glucose metabolism in patients with acute stroke and no previous diagnosis of diabetes mellitus. Q J Med. 2005 ; 98 : 871 - 78. 11. Gentile NT, Seftchick MW, Huynh T, Kruus LK, Gaughan J. Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad Emerg Med. 2006 ; 13 : 174-80. 12. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up study. BMJ. 1997 ; 314 : 1303-6. 13. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients : a systematic overview. Stroke. 2001 ; 32 : 2426 - 32. 14. Kagansky N, Levy S, Knobler H. The role of hyperglycemia in acute stroke. Arch Neurol. 2001 ; 58 : 1209 - 12. 15. Fuentes B, Casarrubios MAO, Jose BS, Castillo J, Leira R, Serena J, et al. Persistent hyperglycemia >155 mg/dl in acute ischemic stroke patients : how well are we correcting it? : implications for outcome. Stroke. 2010 ; 41 : 2362 - 65. 16. Baird TA, Parsons MW, Phanh T, Butcher KS, Desmond PM, Tress BM, et al. Persistent poststroke hyperglycemia is independently associated with

64

infarct expansion and worse clinical outcome. Stroke. 2003 ; 34 : 2208 14. 17. Christensen H. Acute stroke : a dynamic process. Dan Med Bull. 2007 ; 54 : 210 - 25. 18. The European Stroke Organisation (ESO) Executive Comittee and The ESO Writing Committe. Guidelines for management of ischaemic stroke and transient ischaemic attack. Cerebrovasc Disc. 2008 ; 25 : 457 - 507. 19. Johnston KC, Hall CE, Kissela BM, Bleck TP, Conaway MR. Glucose regulation in acute stroke patients (GRASP) trial : a randomized pilot trial. Stroke. 2009 ; 40(12) : 3804 - 9. 20. Kernan WN, Viscoli CM, Inzucchi SE, Brass LM, Bravata DM, Shulman GI, et al. Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke. Arch Intern Med. 2005 ; 165 : 227 33. 21. Penatalaksanaan hiperglikemia pada stroke akut. In : Misbach J, Lumbantobing SM, Lamsudin R, Ranakusuma TAS, Alfa AY, Baoezier F, et al, editors. Guideline stroke 2007. Jakarta : Kelompok Studi Stroke PERDOSSI ; 2007. p. 59 - 66. 22. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004 ; 79(8) : 992 - 1000. 23. Pittas AG, Siegel RD, Lau J. Insulin therapy for critically ill hospitalized patients. Arch Intern Med. 2004 ; 164 : 2005 - 11.

65

24. Fogelholm R, Murros K, Rissanen A, Avikainen S. Admission blood glucose and short term survival in primary intracerebral haemorrhage : a population based study. J Neurol Neurosurg Psychiatry. 2005 ; 76 : 34953. 25. Matz K, Keresztes K, Tatschl C, Nowotny M, Dachenhausen A, Brainin M, et al. Disorders of glucose metabolism in acute stroke patients. Diabetes Care. 2006 ; 29 : 792-7. 26. Gelgel AM. Hubungan kadar gula darah puasa penderita stroke non hemoragik waktu masuk rumah sakit dengan hasil neurologik memakai tolok ukur skala Koma Glasgow dan indeks Barthel [tesis]. Semarang (Indonesia) : Universitas Diponegoro ; 1996. 27. Basu S, Sanyal D, Kroy, Bhattacharya KB. Is post-stroke hyperglycemia a marker of stroke severity and prognosis : a pilot study. Neurology Asia. 2007 ; 13-19. 28. Martin A, Rojas S, Chamorro A, Falcon C, Bargallo N, Planas AM. Why does acute hyperglycemia worsen the outcome of transient focal cerebral ischemia? : Role of corticosteroids, inflammation and protein Oglycosylation. Stroke. 2006 ; 37 : 1288 - 95. 29. National Institute of Neurological Disorders and Stroke. New tool allows early prediction 2010

May

21

;

cited

2010

Dec2].

Available

from

:

http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_str oke_outcome_063001.htm

66

30. Kasner SE, Chalela JA, Luciano JM, Cucchiara BL, Raps EC, McGarvey ML, et al. Reliability and validity of estimating the NIH stroke scale score from medical records. Stroke. 1999 ; 30 : 1534 - 37. 31. Baird AE, Dambrosia J, Janket SJ, Eichbaum Q, Chaves C, Silver B, et al. A three-item scale for the early prediction of stroke recovery. Lancet. 2001 ; 357 : 2095 - 99. 32. National Institutes of Health Stroke Scale [internet]. California (USA). c2010 [updated 2010 ; cited 2011 Jan 7]. Available from : http://www.nihstrokescale.org/ 33. Endress M, Dirnagl U. Ischemia and stroke. In : Alzheimer C, editor. Molecular and cellular biology of neuroprotection in the CNS. New York : Kluwer Academic/Plenum Publishers ; 2002. p. 455 - 72. 34. Endocrine functions of the pancreas & regulation of carbohydrate metabolism. In : Ganong WF, editor. Review of medical physiology. 21st ed. San Fransisco : McGraw-Hill ; 2003. 35. Noerjanto M. Management of acute stroke : masalah-masalah dalam diagnosis stroke akut. Semarang (Indonesia) : Badan Penerbit Undip ; 2002. 36. Misbach J, Jannis J, Kiemas LS. Stroke, aspek diagnostik, patofisiologi, manajemen. Jakarta : Balai Penerbit FKUI ; 1999 ; p. 46 - 54. 37. Markus HS. An introduction to stroke. In : Markus HS, editor. Stroke genetics. New York : Oxford University Press ; 2003. p. 1 - 30.

67

38. Furie KL, Smirnakis Sm, Koroshetz JW, Kitsler JP. Stroke due to large artery atherosclerosis. In : Furie KL, Kelly PJ, editors. Handbook of stroke prevention in clinical practice. New Jersey : Humana Press ; 2004. p. 151 66. 39. Basic pathology, anatomy, and pathophysiology of stroke. In : Caplan LR, th

ed. Philadelphia : Saunders

; 2009. p. 22 - 63. 40. Ginsberg MD. Adventures in the pathophysiology of brain ischemia : penumbra, gene expression, neuroprotection. Stroke. 2003 ; 34 : 214 - 23. 41. Joesoef AA. Aspek biomolekuler dari iskemia otak akut. Pendidikan kedokteran berkelanjutan : stroke in depth now and the future, di Surabaya ; 2004 Mar 13 - 14. Surabaya (Indonesia) : FK Universitas Airlangga ; 2004. 42. Syntichaki P, Tavernarakis N. The biochemistry of neuronal necrosis : rogue biology?. Nature Reviews. 2003 ; 4 : 672 - 84. 43. Royter V, Gur AY, Bova I, Bornstein NM. Hyperglycemia and acute ischemic stroke. Isr Med Assoc J. 2004 ; 6 : 607 - 9. 44. Batjer HH, Caplan LR, Friberg L, Greenlee RG, Kopitnik TA, Young WL. Cerebrovascular disease. Philadelphia : Lippincot-Raven ; 1997. p. 23 40. 45. Iskandar J. Panduan praktis pencegahan dan pengobatan stroke : stroke iskemik. Jakarta (Indonesia) : PT Bhuna Ilmu Populer Kelompok Gramedia ; 2002.

68

46. Sacco RL, Adams RJ, Albers GW, Alberts MJ, Benavente O, Furie KL, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. Stroke. 2006 ; 37 : 577 - 617. 47. Han J, Bae HJ, Wong LKS. Pathophysiology and mechanism whereby hypertension may cause stroke. In : Aiyagari V, Gorelick PB, editors. Hypertension and stroke : pathophysiology and management. New York : Humana Press ; 2011. p. 77 - 96. 48. Stoll G, Bendszus M. Inflammation and atherosclerosis : novel insights into plaque formation and destabilization. Stroke. 2006 ; 37 : 1923 - 32. 49. Gott AM. Evolving concepts of dyslipidemia, atherosclerosis, and cardiovascular disease. J Am Coll Cardiol. 2005 ; 46 : 1219 - 24. 50. Gau GT, Wright RS. Pathophysiology, diagnosis, and management of dyslipidemia. Curr Probl Cardiol. 2006 ; 31 : 445 - 86. 51. Tahapan terjadinya aterosklerosis. In : Tugasworo D, editor. Patogenesis aterosklerosis. Semarang : Badan Penerbit Universitas Diponegoro ; 2010. p. 15 - 24. 52. Modifiable lifestyle and environmental factors. In : Wiebers DO, Feigin VL, Brown RD, editors. Handbook of stroke. 2nd ed. Philadelphia : Lippincott Williams & Wilkins ; 2006. p. 305 - 11. 53. Sangiorgi G, Mauriello A, Kolodgie F, Trimarchi S, Zoccai GB, Virmani R, et al. Pathobiology of the asymptomatic atherosclerotic carotid plaque. In : Moussa ID, Rundek T, Mohr JP, editors. Asymptomatic carotid artery

69

stenosis : risk stratification and management. London : Informa Healthcare ; 2007. p. 19 - 38. 54. Rundek T, Meyers PM, Crutchfield K. Cerebrovascular anatomy and physiology and mechanism of first-ever ischemic stroke in patients with carotid artery stenosis. In : Moussa ID, Rundek T, Mohr JP, editors. Asymptomatic carotid artery stenosis : risk stratification and management. London : Informa Healthcare ; 2007. p. 39 - 62. 55. Mayes PA. Biokimia Harper edisi ke 25. Jakarta : EGC ; 2002 ; p. 195 204. 56. Cryer PE. Williams textbook of endocrinology. 8th ed. Philadelphia : WB Saunders Company ; 1992 ; 1223 - 48. 57. Stover JF, Sakowitz OW, Thomale UW, Kroppenstedt SN, Unterberg AW. Norepinephrine-induced hyperglycemia does not increase lactate in brain injured. J Intensive Care Med. 2002 ; 28 (10) : 1491 - 7. 58. Neuroendocrine control of metabolism and growth. In : Longstaff A, editor. Neuroscience. 1st ed. Oxford : BIOS Scientific Publisher Ltd ; 2000. p. 274 - 82. 59. Romero LM, Butler LK. Endocrinology of stress. Int J Comp Psychol. 2007 ; 20 : 89 - 95. 60. Martini SR, Kent TA. Hyperglycemia in acute ischemic stroke : a vascular perspective. J Cereb Blood Flow Metab. 2007 ; 27 : 435 - 51. 61. for neuroprotection. J Neurol Neurosurg Psychiatry. 1999 ; 67 : 1 - 3.

70

62. Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest. 2001 ; 108 : 1341 - 48. 63. Cai S, Khoo J, Channon KM. Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells. Cardiovasc Res. 2005 ; 65 : 823 - 31. 64. Cosentino F, Eto M, Paolis PD, Loo BVD, Bachschmid M, Ullrich V, et al. High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells : role of protein kinase C and reactive oxygen species. Circulation. 2003 ; 107 : 1017 - 23. 65. Cosentino F, Hishikawa K, Katusic ZS, Luscher TF. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation. 1997 ; 96 : 25 - 8. 66. Ding QF, Hayashi T, Packiasamy ARJ, Miyazaki A, Fukatsu A, Shiraishi H, et al. The effect of high glucose on NO and O2 through endothelial GTPCH1 and NADPH oxidase. Life Sci. 2004 ; 75 : 3185 - 94. 67. Aronson D, Rayfield EJ. How hyperglycemia promotes atherosclerosis : molecular mechanism. Cardiovasc Diabetol. 2002 ; 1 : 1-10. 68. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, et al. High glucose level and free fattty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NADPH oxidase in cultured vascular cells. Diabetes. 2000 ; 49 : 1939 - 45.

71

69. Forstermann U, Munzel T. Endothelial nitric oxide synthase in vascular disease : from marvel to menace. Circulation. 2006 ; 113 : 1708 - 14. 70. Sercombe R, Vicaut E, Oudart N, Sercombe C, Girard P. Acetylcholineinduced relaxation of rabbit basilar artery in vitro is rapidly reduced by reactive oxygen species in acute hyperglycemia. J Cardiovasc Pharmacol. 2004 ; 44 : 507 - 16. 71. Morigi M, Angioletti S, Imberti B, Donadelli R, Micheletti G, Figliuzzi M, et al. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-

-dependent fashion. J Clin

Invest. 1998 ; 101 (9) : 1905 - 15. 72. Andersen SK, Gjedsted J, Christiansen C, Tonnesen E. The roles of insulin and hyperglycemia in sepsis pathogenesis. J Leukoc Biol. 2004 ; 75 : 413 21. 73. Maxwell WL. Cellular responses to ischaemic CNS injury. In : Berry M, Logan A, editors. CNS injuries : cellular responses and pharmacological strategies. New York : CRC Press ; 1999. 74. Coppede F, Migliore L. Genetic and environmental factors in neurodegenerative diseases. In : Qureshi GA, Parvez SH, editors. Oxidative stress and neurodegenerative disorders. Amsterdam : Elsevier ; 2007. p. 89 - 114. 75. Turner

AJ,

Nalivaeva

NN.

New

insights

into

the

roles

of

metalloproteinases in neurodegeneration and neuroprotection. In : Bagetta

72

G, Corasaniti MT, Lipton SA, editors. The neuroinflammation in neuronal death and repair. California : Elsevier ; 2007. p. 114 - 36. 76. Vermeer SE, Sandee W, Algra A, Koudstaal P, Kappelle J, Dippel DWJ, et al. Impaired glucose tolerance increases stroke risk in nondiabetic patients with transient ischemic attack or minor ischemic stroke. Stroke. 2006 ; 37 : 1413 - 17. 77. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack. Stroke. 2011 ; 42 : 227 - 76. 78. Park JW, Lee SY, Kim SY, Choe H, Jee SH. BMI and stroke risk in korean women. Obesity. 2008 ; 16 : 396 - 401. 79. Chen HJ, Bai CH, Yeh WT, Chiu HC, Pan WH. Influence of metabolic syndrome and general obesity on the risk of ischemic stroke. Stroke. 2006 ; 37 : 1060 - 64. 80. Ni K, Naz L, Mushtaq S, Rukh L, Ali S, Hussain Z. Ischemic stroke : prevalence of modifiable risk factors in male and female patients in Pakistan. Pak J Pharm Sci. 2009 ; 22 : 62 - 7. 81. Mehta S. The glucose paradox of cerebral ischaemia. J Postgrad Med. 2003 ; 49 : 299 - 301 82. Furie KL, Singhal AB, Kistler JP. Cardiac embolism. In : Furie KL, Kelly PJ, editors. Handbook of stroke prevention in clinical practice. New Jersey : Humana Press ; 2004. p. 187 - 98.

73

83. Furie KL, Lev MH, Koroshetz WJ, Greer DM. Evaluation of acute stroke etiologies. In : Greer DM, editor. Acute ischemic stroke : an evidencebased approach. New Jersey : John Wiley & Sons ; 2007. p. 197 - 212

74

75

JUDUL PENELITIAN PENGARUH KADAR GLUKOSA DARAH SEWAKTU TERHADAP KELUARAN NEUROLOGIK PADA PENDERITA STROKE ISKEMIK FASE AKUT NONDIABETIK INSTANSI PELAKSANA

: RS DR. KARIADI SEMARANG

PERSETUJUAN SETELAH PENJELASAN (INFORMED CONSENT)

Berikut ini naskah yang akan dibacakan pada Responden / Keluarga Responden Penelitian : Bapak / Ibu / Sdr Yth Anda terpilih sebagai responden penelitian yang berhubungan dengan kadar glukosa darah sewaktu sebagai faktor risiko pada penderita stroke yang anda / keluarga anda alami. Tindakan yang akan Bapak / Ibu / Sdr alami : Dilakukan anamnesis (menggunakan kuesioner) dan pemeriksaan fisik neurologik (menggunakan palu reflek dan senter). Pengambilan sampel darah untuk pemeriksaan kadar glukosa darah yang akan dilaksanakan 2 kali, pertama saat pasien masuk ke bangsal rawat inap penyakit saraf dan kedua setelah 24 jam berikutnya. Dilakukan penilaian status neurologik menggunakan skor NIHSS pada perawatan hari ke 0, 1 dan saat pasien pulang atau hari ke 7. Terimakasih atas kerjasama Bapak / Ibu / Sdr. Setelah mendengar dan memahami penjelasan peneliti, dengan ini saya menyatakan SETUJU / TIDAK SETUJU untuk ikut sebagai responden penelitian. Semarang, ................................ Peserta penelitian

(

Saksi

)

(

Peneliti

)

(dr. Edward Y.N)

76

DAFTAR PERTANYAAN DATA DASAR PENELITIAN NO. 1 2 3 4

PERTANYAAN IDENTITAS Nomor penelitian Tanggal pemeriksaan Nama Alamat

5 6 7

Nomor CM/Register Tanggal/jam masuk RS Jenis kelamin

8 9

Umur (tahun) Status perkawinan

10

Pendidikan

11

Pekerjaan

12 13 14

ANAMNESIS Defisit neurologis Tanggal/jam serangan Kedinian datang ke RS

15

Riwayat DM

16

Riwayat hipertensi

17

Riwayat merokok

18

PEMERIKSAAN FISIK Tinggi badan (cm)

JAWABAN

1. Laki-laki 2. Perempuan 1. Kawin 2. Janda/duda 3. Belum kawin 1. SD 2. SLTP 3. SLTA 4. S1 5. Tidak sekolah 1. PNS / TNI 2. Wiraswasta 3. Pedagang 4. Buruh / Tani 5. Tidak bekerja

1. < 48 jam 2. 49 - 72 jam 1. Ya 2. Tidak 1. Ya 2. Tidak 1. Ya 2. Tidak

77

19 20

Berat badan (kg) Body Mass Index

21 22 23 24 25 26

Glasgow Coma Scale Tekanan darah (mmHg) Nadi (x/menit) Suhu (°C) Pernafasan (x/menit) Jantung

27

Pemeriksaan EKG

31

PEMERIKSAAN NEUROLOGIS Skor NIHSS < 48 jam onset Skor NIHSS 49 - 72 jam onset Skor NIHSS hari ke 7 onset PEMERIKSAAN PENUNJANG Lokasi infark

32 33 34 35 36

Kadar Hb (gr%) Leukosit (mm3) Trombosit (mm3) Hematokrit (%) Kadar glukosa darah sewaktu

37 38 39 40

Kadar kolesterol total (mg%) Kadar Trigliserida (mg%) Kadar HDL (mg%) Kadar LDL (mg%) KETERANGAN Alasan pulang sebelum hari ke 7 onset

28 29 30

41

1. Kurus (< 18,5) 2. Nomal (18,5-25) 3. Overweight (25-30) 4. Obesitas (> 30)

1. Normal 2. Tidak normal 1. Normal 2. Tidak normal

1. Kortikal 2. Subkortikal 3. Batang otak 4. Campuran 5. Normal

1. < 48 jam onset 2. 49 - 72 jam onset 3. Hari ke 7 onset

78

NATIONAL INSTITUTES OF HEALTH STROKE SCALES (NIHSS)

NIHSS 1a

1b

1c

2

3

4

5a

5b 6a

Derajat kesadaran 0 = sadar penuh 1 = somnolen 2 = stupor 3 = tidak respon atau hanya terdapat reflek Menjawab pertanyaan 0 = dapat menjawab dua pertanyaan dengan benar (misalnya bulan apa sekarang dan usia pasien) 1 = hanya dapat menjawab satu pertanyaan dengan benar / tidak dapat berbicara karena terpasang pipa endotrakeal atau disartria 2 = tidak dapat menjawab kedua pertanyaan dengan benar / afasia / stupor Mengikuti perintah 0 = dapat melakukan dua perintah dengan benar (misalnya buka dan tutup mata, kepal dan buka tangan pada sisi yang sehat) 1 = hanya dapat melakukan satu perintah dengan benar 2 = tidak dapat melakukan kedua perintah dengan benar Gerakan mata konyugat horisontal 0 = normal 1 = kelumpuhan parsial 2 = deviasi konyugat yang kuat atau paresis konyugat total pada kedua mata, tidak dapat diatasi dengan manuver okulosefalik Lapangan pandang pada tes konfrontasi 0 = tidak ada gangguan 1 = hemianopia parsial 2 = hemianopsia total 3 = hemianopsia bilateral (termasuk juga buta kortikal) Paresis wajah 0 = normal 1 = paresis ringan (sulkus nasolabialis mendatar, terdapat asimetri) 2 = paresis parsial (paresis total/hampir total wajah bagian bawah) 3 = paresis total (tidak ada gerakan dari wajah atas dan bawah) Motorik lengan kiri 0 = tidak ada simpangan bila pasien disuruh mengangkat lengannya pada posisi 90°/45° selama 10 detik 1 = lengan menyimpang ke bawah sebelum 10 detik 2 = lengan terjatuh ke kasur atau badan atau tidak dapat diluruskan secara penuh 3 = tidak dapat melawan gravitasi 4 = tidak ada gravitasi 9 = tidak dapat diperiksa Motorik lengan kanan (idem) Motorik tungkai kiri 0 = tidak ada simpangan bila pasien disuruh mengangkat tungkai pada posisi 30° selama 5 detik 1 = tungkai menyimpang ke bawah sebelum 5 detik 2 = tungkai terjatuh ke kasur atau tidak dapat diluruskan secara penuh 3 = tidak dapat melawan gravitasi 4 = tidak ada gravitasi 9 = tidak dapat diperiksa

1

2

3

79

6b 7

Motorik tungkai kanan (idem) Ataksia anggota badan 0 = tidak 1 = pada satu sisi 2 = pada kedua sisi 9 = tidak dapat diperiksa 8 Sensorik 0 = normal 1 = defisit ringan-sedang 2 = defisit berat (gangguan rasa raba pada wajah, lengan dan tungkai) 9 Bahasa terbaik 0 = tidak ada afasia 1 = afasia ringan sedang 2 = afasia berat 3 = mutisme 10 Disartria 0 = artikulasi normal 1 = disartria ringan sedang (masih dapat dimengerti) 2 = disartria berat 9 = tidak dapat diperiksa 11 Neglect / tidak ada atensi 0 = tidak ada 1 = gangguan bilateral dari salah satu modalitas berikut : pengenalan personal, visual, taktil, dan spasial 2 = gangguan pada lebih dari satu modalitas SKOR TOTAL NIHSS

80

HASIL ANALISIS DATA Je nis ke lam in * Kate gori NIHSS hari ke 7 Cros s tabulation

Ringan Jenis kelamin

Laki-laki Perempuan

Total

Count % of Total Count % of Total Count % of Total

7 21,9% 5 15,6% 12 37,5%

Kategori NIHSS hari ke 7 Sedang Berat Sangat berat 9 1 2 28,1% 3,1% 6,3% 7 1 0 21,9% 3,1% ,0% 16 2 2 50,0% 6,3% 6,3%

Total 19 59,4% 13 40,6% 32 100,0%

Des criptives Umur

Mean 95% Conf idence Interval f or Mean

Statistic 53,94 50,58

Low er Bound Upper Bound

Std. Error 1,649

57,30

5% Trimmed Mean Median Varianc e Std. Deviation Minimum Max imum Range Interquartile Range Skew nes s Kurtosis

53,85 53,00 86,964 9,325 34 74 40 13 ,188 -,155

,414 ,809

um ur 51 * Kategori NIHSS hari k e 7 Cross tabulation

Ringan umur 51

<51 tahun

Count % w ithin Kategori NIHSS hari ke 7 Count % w ithin Kategori NIHSS hari ke 7 Count % w ithin Kategori NIHSS hari ke 7

=51 tahun

Total

4

Kategori NIHSS hari ke 7 Sedang Berat Sangat berat 6 1 1

33,3%

37,5%

50,0%

50,0%

37,5%

8

10

1

1

20

66,7%

62,5%

50,0%

50,0%

62,5%

12

16

2

2

32

100,0%

100,0%

100,0%

100,0%

100,0%

Riw ayat Hipe rte ns i * Kate go ri NIHSS h ari ke 7 Cros s tab ulatio n

Ringan Riw ayat Hipertens i

+ -

Total


Total 12

9 28,1% 3 9,4% 12 37,5%

Kategori NIHSS hari ke 7 Sedang Berat Sangat berat 12 2 2 37,5% 6,3% 6,3% 4 0 0 12,5% ,0% ,0% 16 2 2 50,0% 6,3% 6,3%

Total 25 78,1% 7 21,9% 32 100,0%

81

Dis lipide m ia * Kategori NIHSS hari k e 7 Cros stabulation

Dislipidemia

+ -

Total

Kategori NIHSS hari ke 7 Sedang Berat Sangat berat 11 1 2 34,4% 3,1% 6,3% 5 1 0 15,6% 3,1% ,0% 16 2 2 50,0% 6,3% 6,3%

Ringan 11 34,4% 1 3,1% 12 37,5%


Total 25 78,1% 7 21,9% 32 100,0%

Me rokok * Kategori NIHSS hari k e 7 Cros stabulation Kategori NIHSS hari ke 7 Sedang Berat Sangat berat 5 0 1 15,6% ,0% 3,1% 11 2 1 34,4% 6,3% 3,1% 16 2 2 50,0% 6,3% 6,3%

Ringan Merokok

+


Total

3 9,4% 9 28,1% 12 37,5%

Total 9 28,1% 23 71,9% 32 100,0%

Infark Miokard * Kategori NIHSS hari k e 7 Cros stabulation

Ringan Inf ark Miokard

+ -

Total


5 15,6% 7 21,9% 12 37,5%

Kategori NIHSS hari ke 7 Sedang Berat Sangat berat 3 0 1 9,4% ,0% 3,1% 13 2 1 40,6% 6,3% 3,1% 16 2 2 50,0% 6,3% 6,3%

Total 9 28,1% 23 71,9% 32 100,0%

BMI * Kateg ori NIHSS h ari ke 7 Cr os stabulation

Ringan BMI

Total

Normal (18,5 - 25)

Count % w ithin Overw eight (25 - 30) Count % w ithin Obesitas (> 30) Count % w ithin Count % w ithin

BMI BMI BMI BMI

7 35,0% 4 40,0% 1 50,0% 12 37,5%

Kategori NIHSS hari ke 7 Sedang Berat Sangat berat 11 1 1 55,0% 5,0% 5,0% 5 0 1 50,0% ,0% 10,0% 0 1 0 ,0% 50,0% ,0% 16 2 2 50,0% 6,3% 6,3%

Total 20 100,0% 10 100,0% 2 100,0% 32 100,0%

82

Des criptives GDS < 48 jam

Mean 95% Confidence Interval for Mean


5% Trimmed Mean Median Variance Std. Deviation Minimum Max imum Range Interquartile Range Skew nes s Kurtosis

Statistic 117,47 106,74

Std. Error 5,260

128,20 115,69 106,00 885,289 29,754 73 194 121 35 1,073 ,639

,414 ,809

Tes ts of Norm ality a

GDS < 48 jam

Kolmogorov-Smirnov Statistic df Sig. ,187 32 ,006

Statistic ,904

Shapiro-Wilk df 32

Sig. ,008

a. Lilliefors Signif icance Correction

Des criptives GDS 49 - 72 jam



5% Trimmed Mean Median V arianc e Std. Deviation Minimum Max imum Range Interquartile Range Skew nes s Kurtosis

Statistic 115,06 105,46

Std. Error 4,707

124,66 113,52 108,00 708,899 26,625 71 182 111 32 1,070 ,772

,414 ,809

Tes ts of Nor m ality a

GDS 49 - 72 jam


a. Lillief ors Signif icance Correc tion

Statistic ,906

Shapiro-Wilk df 32

Sig. ,009

83

Des criptives KOL. TOTA L

TRIGLISERIDA

HDL

LDL

Mean 95% Conf idence Interval f or Mean 5% Trimmed Mean Median V arianc e Std. Deviation Minimum Max imum Range Interquartile Range Skew nes s Kurtosis Mean 95% Conf idence Interval f or Mean 5% Trimmed Mean Median V arianc e Std. Deviation Minimum Max imum Range Interquartile Range Skew nes s Kurtosis Mean 95% Conf idence Interval f or Mean 5% Trimmed Mean Median V arianc e Std. Deviation Minimum Max imum Range Interquartile Range Skew nes s Kurtosis Mean 95% Conf idence Interval f or Mean 5% Trimmed Mean Median V arianc e Std. Deviation Minimum Max imum Range Interquartile Range Skew nes s Kurtosis





Statistic 202,75 189,81

Std. Error 6,344

215,69 202,83 202,50 1287,742 35,885 129 280 151 44 -,034 -,110 122,13 102,73

,414 ,809 9,512

141,52 117,31 105,00 2895,145 53,807 61 273 212 48 1,492 1,850 43,81 40,82

,414 ,809 1,468

46,81 43,40 40,50 68,931 8,302 32 63 31 11 ,772 -,061 125,56 114,71

,414 ,809 5,322

136,42 124,92 122,50 906,190 30,103 79 184 105 38 ,427 -,530

,414 ,809

84

Tes ts of Normality a

KOL. TOTAL TRIGLISERIDA HDL LDL

Kolmogorov-Smirnov Statistic df Sig. ,100 32 ,200* ,189 32 ,005 ,177 32 ,012 ,140 32 ,115

Statistic ,986 ,842 ,925 ,943

Shapiro-Wilk df 32 32 32 32

Sig. ,938 ,000 ,028 ,089

*. This is a low er bound of the true signif icance. a. Lillief ors Signif icance Correction

Je nis ke lam in * Kate gori NIHSS hari 7Gabung Cr os stabulation

Jenis kelamin

Laki-laki Perempuan

Total

Count Ex pected Count Count Ex pected Count Count Ex pected Count

Kategori NIHSS hari 7Gabung Sedang+ Berat+Sangat Ringan Berat 7 12 7,1 11,9 5 8 4,9 8,1 12 20 12,0 20,0

Total 19 19,0 13 13,0 32 32,0

Chi-Square Te s ts

Pearson Chi-Square Continuity Correctiona Likelihood Ratio Fisher's Exact Test Linear-by -Linear Ass ociation N of Valid Cas es

Value ,009 b ,000 ,009

,008

df 1 1 1

1

Asy mp. Sig. (2-s ided) ,926 1,000 ,926

Exac t Sig. (2-s ided)

Exac t Sig. (1-s ided)

1,000

,607

,927

32

a. Computed only for a 2x2 table b. 1 cells (25,0%) have expec ted count less than 5. The minimum expec ted count is 4,88.

85

Riw ayat Hipe rte ns i * Kategori NIHSS hari 7Gabung Cross tabulation

Riw ayat Hipertens i + Total

Count Expected Count Count Expected Count Count Expected Count


Total 25 25,0 7 7,0 32 32,0

Chi-Square Te s ts

Pearson Chi-Square Continuity Correctiona Likelihood Ratio Fisher's Exact Test Linear-by -Linear Association N of Valid Cases

Value ,110 b ,000 ,108

df 1 1 1

,106

Asymp. Sig. (2-sided) ,740 1,000 ,742

1

Ex act Sig. (2-sided)


1,000

,535

,744

32

a. Computed only for a 2x 2 table b. 2 cells (50,0%) hav e expec ted count les s than 5. The minimum expected count is 2,63.

Dis lipide m ia * Kategori NIHSS hari 7Gabung Cros stabulation

Dislipidemia

+ -

Total



Total 25 25,0 7 7,0 32 32,0

Chi-Square Te s ts


Value 2,060b ,987 2,302

1,996

df 1 1 1

1

Asymp. Sig. (2-sided) ,151 ,320 ,129



,212

,161

,158

32


86

Me rokok * Kategori NIHSS hari 7Gabung Cros stabulation

Merokok

+


Total


Total 9 9,0 23 23,0 32 32,0

Chi-Square Te s ts


Value ,093 b ,000 ,094

df 1 1 1

,090

Asymp. Sig. (2-sided) ,761 1,000 ,760

1



1,000

,546

,764

32

a. Computed only for a 2x 2 table b. 1 cells (25,0%) hav e expec ted count les s than 5. The minimum expected count is 3,38. Infark Miokard * Kategori NIHSS hari 7Gabung Cros stabulation

Inf ark Miokard

+ -

Total



Total 9 9,0 23 23,0 32 32,0

Chi-Square Te s ts


Value 1,742b ,835 1,708

1,687

df 1 1 1

1

Asymp. Sig. (2-sided) ,187 ,361 ,191



,240

,180

,194

32


87

Kolmogorov Smirnov BMI dengan NIHSS hari ke 7 Fr eque ncies BMI

Kategori NIHSS Ringan Sedang+Berat+ Sangat Berat Total

N 12 20 32

Tes t Statis ticsa Mos t Ex treme Dif f erences

BMI ,067 ,067 ,000 ,183 1,000

A bs olute Positive Negative

Kolmogorov-Smirnov Z A sy mp. Sig. (2-tailed)

a. Grouping V ariable: Kategori NIHSS hari 7Gabung

Skor NIHSS <48 jam Des criptives Skor NIHSS < 48 jam

Mean 95% Confidence Interval f or Mean


5% Trimmed Mean Median Variance Std. Deviation

Statistic 9,78 6,43 13,13 8,80 7,00 86,176 9,283 1 37 36 8 1,838 2,715

Minimum Maximum Range Interquartile Range Skew nes s Kurtosis

Std. Error 1,641

,414 ,809

Tes ts of Nor m ality a

Skor NIHSS < 48 jam


a. Lilliefors Significance Correction

Statistic ,753

Shapiro-Wilk df 32

Sig. ,000

88

Kate gori NIHSS < 48 jam

V alid

Ringan Sedang Berat Sangat berat Total

Frequency 11 16 1 4 32

Percent 34,4 50,0 3,1 12,5 100,0

Cumulativ e Percent 34,4 84,4 87,5 100,0

V alid Percent 34,4 50,0 3,1 12,5 100,0

Skor NIHSS 49-72 jam Des criptives Skor NIHSS 49 - 72 jam



5% Trimmed Mean Median Variance Std. Deviation Minimum Max imum Range Interquartile Range Skew ness Kurtosis

Statistic 9,31 6,05

Std. Error 1,601

12,58 8,30 6,50 82,028 9,057 1 37 36 8 1,878 3,145

,414 ,809


Skor NIHSS 49 - 72 jam


Statistic ,767

Shapiro-Wilk df 32

a. Lillief ors Signif icance Correc tion

Kate gori NIHSS 49 - 72 jam

V alid


Frequenc y 11 16 3 2 32

Percent 34,4 50,0 9,4 6,3 100,0

V alid Percent 34,4 50,0 9,4 6,3 100,0


Sig. ,000

89

Des criptives Skor NIHSS hari ke 7



5% Trimmed Mean Median V arianc e Std. Deviation Minimum Max imum Range Interquartile Range Skew nes s Kurtosis

Statistic 8,00 4,83

Std. Error 1,552

11,17 6,90 5,50 77,097 8,780 0 37 37 7 2,269 5,059

,414 ,809



Skor NIHSS hari ke 7

Statistic ,714

Shapiro-Wilk df 32

a. Lilliefors Significance Correc tion

Kate go ri NIHSS hari ke 7

V alid


Frequenc y 12 16 2 2 32

Percent 37,5 50,0 6,3 6,3 100,0

Friedman Test Ranks Skor NIHSS < 48 jam Skor NIHSS 49 - 72 jam Skor NIHSS hari ke 7 Tes t Statis ticsa N Chi-Square df A sy mp. Sig.

32 39,973 2 ,000

a. Friedman Test

Mean Rank 2,47 2,20 1,33

V alid Percent 37,5 50,0 6,3 6,3 100,0


Sig. ,000

90

Analisis Post Hoc Wilcoxon Ranks N Skor NIHSS hari ke 7 Skor NIHSS < 48 jam

Skor NIHSS hari ke 7 Skor NIHSS 49 - 72 jam

Skor NIHSS 49 - 72 jam - Skor NIHSS < 48 jam

23 a 0b 9c 32 20 d 0e 12 f 32 7g 0h 25 i 32

Negative Ranks Positive Ranks Ties Total Negative Ranks Positive Ranks Ties Total Negative Ranks Positive Ranks Ties Total

Mean Rank 12,00 ,00

Sum of Ranks 276,00 ,00

10,50 ,00

210,00 ,00

4,00 ,00

28,00 ,00

a. Skor NIHSS hari ke 7 < Skor NIHSS < 48 jam b. Skor NIHSS hari ke 7 > Skor NIHSS < 48 jam c. Skor NIHSS hari ke 7 = Skor NIHSS < 48 jam d. Skor NIHSS hari ke 7 < Skor NIHSS 49 - 72 jam e. Skor NIHSS hari ke 7 > Skor NIHSS 49 - 72 jam f . Skor NIHSS hari ke 7 = Skor NIHSS 49 - 72 jam g. Skor NIHSS 49 - 72 jam < Skor NIHSS < 48 jam h. Skor NIHSS 49 - 72 jam > Skor NIHSS < 48 jam i. Skor NIHSS 49 - 72 jam = Skor NIHSS < 48 jam

Tes t Statisticsb

Z A sy mp. Sig. (2-tailed)

Skor NIHSS hari ke 7 Skor NIHSS < 48 jam -4,268a ,000

a. Based on positive ranks . b. Wilc oxon Signed Ranks Tes t

Skor NIHSS hari ke 7 Skor NIHSS 49 - 72 jam -4,089a ,000

Skor NIHSS 49 - 72 jam Skor NIHSS < 48 jam -2,392a ,017

91

20

15

10

5

0 73 81 86 92 93 97 100 103 105 107 108 113 116 119 125 127 135 140 141 157 163 168 186 194

gds_0

D_NIHSS2 30

20

10

0 Observed -10

Linear 0

100

200

300

400

GDS_0

D_NIHSS2 = selisih NIHSS 48 jam onset dengan hari ke 7 onset

92

Cas e Proces s ing Sum m ary GDS_0 Positivea Negative Mis sing

V alid N (listw ise) 3 33 1

Larger values of the tes t res ult variable(s ) indicate stronger ev idenc e f or a positive ac tual s tate. a. The positive ac tual s tate is 105.

ROC Curve 1.00

.75

.50

.25

0.00 0.00

.25

.50

.75

1.00

1 - Specificity Diagonal segments are produced by ties.

Are a Under the Cur ve Test Result V ariable(s ): D_NIHSS2

A rea .571

a

Std. Error .112

A sy mptotic b Sig. .689

A sy mptotic 95% Conf idence Interval Low er Bound Upper Bound .351 .790

The test result variable(s ): D_NIHSS2 has at least one tie betw een the positive actual state group and the negative actual state group. Statistic s may be biased. a. Under the nonparametric assumption b. Null hypothesis: true area = 0.5

93

Coordinate s of the Curve Test Res ult V ariable(s ): D_NIHSS2 Positive if Greater Than a or Equal To -1.00 .50 1.50 2.50 11.50 21.00

Sens itiv ity 1.000 1.000 .333 .000 .000 .000

1 - Specif ic ity 1.000 .667 .364 .152 .030 .000

The test result variable(s ): D_NIHSS2 has at leas t one tie betw een the pos itiv e ac tual s tate group and the negative ac tual s tate group. a. The smallest c utof f value is the minimum observ ed tes t value minus 1, and the largest cutoff value is the maximum observ ed tes t value plus 1. All the other cutof f v alues are the av erages of tw o cons ecutive ordered obs erved test values. Cor relations Spearman's rho

GDS_0

D_NIHSS1

D_NIHSS2

Correlation Coeffic ient Sig. (2-tailed) N Correlation Coeffic ient Sig. (2-tailed) N Correlation Coeffic ient Sig. (2-tailed) N

GDS_0 1.000 . 36 .176 .306 36 -.149 .386 36

**. Correlation is s ignificant at the 0.01 level (2-tailed).

Cas e Proces s ing Sum m ary GDS_0 Positivea Negative Mis sing

V alid N (listw ise) 1 35 1

Larger values of the tes t res ult variable(s ) indicate stronger ev idenc e f or a positive ac tual s tate. a. The positive ac tual s tate is 107.

D_NIHSS1 .176 .306 36 1.000 . 36 .671** .000 36

D_NIHSS2 -.149 .386 36 .671** .000 36 1.000 . 36

94

ROC Curve 1.00

.75

.50

.25

0.00 0.00

.25

.50

.75

1.00

1 - Specificity

Are a Under the Cur ve Test Result Variable(s ): D_NIHSS2

Area 1.000

a

Std. Error .000

Asy mptotic b Sig. .092

Asy mptotic 95% Conf idence Interval Low er Bound Upper Bound 1.000 1.000

a. Under the nonparametric assumption b. Null hypothesis: true area = 0.5

Coordinate s of the Curve Test Res ult V ariable(s ): D_NIHSS2 Positive if Greater Than a or Equal To -1.00 .50 1.50 2.50 11.50 21.00

Sens itiv ity 1.000 1.000 1.000 1.000 1.000 .000

1 - Specif ic ity 1.000 .686 .343 .114 .000 .000

a. The smallest c utof f value is the minimum observ ed tes t value minus 1, and the largest cutoff value is the maximum observ ed tes t value plus 1. All the other cutof f v alues are the av erages of tw o cons ecutive ordered obs erved test values.

95

Cas e Proces s ing Sum m ary V alid N (listw ise) 1 35 1

GDS_0 Positivea Negative Mis sing

Larger values of the tes t res ult variable(s) indicate stronger ev idence for a positive ac tual s tate. a. The positive actual s tate is 108.

ROC Curve 1.00

.75

.50

.25

0.00 0.00

.25

.50

.75

1.00

1 - Specificity Diagonal segments are produced by ties.

Regression V ariables Enter ed/Re m ovebd Model 1

V ariables Entered GDS_0a

V ariables Remov ed .

Method Enter

a. A ll requested variables entered. b. Dependent Variable: D_NIHSS2

Model Sum m ary Model 1

R .114 a

R Square .013

A djusted R Square -.016

a. Predictors: (Constant), GDS_0

Std. Error of the Estimate 3.321

96

ANOVAb Model 1

Regression Residual Total

Sum of Squares 4.926 375.074 380.000

df

Mean Square 4.926 11.032

1 34 35

F .447

Sig. .508 a

a. Predictors: (Constant), GDS_0 b. Dependent Variable: D_NIHSS2

Coe fficientsa

Model 1

(Constant) GDS_0

Unstandardiz ed Coef f icients B Std. Error 2.521 1.393 -.006 .010

Standardized Coef f icients Beta -.114

t 1.809 -.668

Sig. .079 .508

a. Dependent Variable: D_NIHSS2

Cut off point kadar GDS 105 mg/dl :

Kate gori NIHSS hari 7Gabung * Hiper glike m ia Cross tabulation Count

Kategori NIHSS hari 7Gabung

Ringan Sedang+Berat+ Sangat Berat

Hiperglikemia Euglikemia Hiperglikemia 7 5

Total

Nilai duga positif

= 11/20 = 55 %

Nilai duga negatif

= 7/12 = 58,3 %

Sensitivitas

= 11/16 = 68,75 %

Spesifisitas

= 7/16 = 43,75 %

Total 12

9

11

20

16

16

32

= (1-specificity) = 9/16 = 56,25 % = (1-sensitivity) = 5/16 = 3,25 % Likelihood ratio positive = 68,75 / 56,25 = 1,2 Likelihood ratio negative = 31,25 / 43,75 = 0,71

DAFTAR PUSTAKA. 1. Konsensus nasional : Pengenalan dan penatalaksanaan demensia alzheimer

Recommend Documents